Accuray Incorporated (ARAY)

View Presentations By Show Results By

Please create an account to view the presentations.

Thomas Rathjen, Vice President, Investor Relations

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company’s leading edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 300,000 patients worldwide have been treated using the Company's technologies and more than 616 systems have been installed in leading hospitals around the world.

About B. Riley & Co.

B. Riley is a FINRA member firm providing research and trading ideas to institutional clients and high net worth individuals, and investment banking services to a wide range of middle-market private and public companies. Founded in 1997, the firm began by successfully targeting small capitalization California-based companies and has won a reputation for providing proprietary, unbiased and often contrarian Equity and High Yield research coverage of companies that are under-followed or misunderstood by Wall Street. At B. Riley, we are singularly focused on under-valued small to mid-cap companies on the West Coast - by identifying possibilities where no one else is looking, we achieve superior long-term returns for our clients. For more information, please visit www.brileyco.com.